Burning Rock Biotech (BNR) Shares Outstanding (Diluted Average) (2020 - 2025)

Burning Rock Biotech's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 1.28% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (up 1.28% YoY), while the FY2025 annual figure was $2.4 million, up 1.28% from the prior year.
• Shares Outstanding (Diluted Average) was $2.4 million for Q4 2025 at Burning Rock Biotech, up from $2.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $13.6 million in Q4 2021 to a low of $2.4 million in Q4 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $6.5 million across 5 years, with a median of $2.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) plunged 82.07% in 2022, then soared 385.04% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $13.6 million in 2021, then slumped by 82.07% to $2.4 million in 2022, then jumped by 385.04% to $11.8 million in 2023, then slumped by 79.59% to $2.4 million in 2024, then increased by 1.28% to $2.4 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $2.4 million (Q4 2025), $2.4 million (Q4 2024), and $11.8 million (Q4 2023), per Business Quant data.